Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2022 Filed Mar 29, 2022 00:18 UTC |
Catinazzo ThomasChief Financial Officer
|
Exercise / conversionCommon Stock | 13,286 | $4.12 | $54,738.32 |
DisclosureSEC source: 0001209191-22-021390 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021. F2 · balance_after: Includes 52,165 shares underlying RSUs. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:11 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021388 · doc4.xml · derivative · entry 3 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,456 Underlying: Common Stock · 10,000 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:11 UTC |
Bergstrom Donald APresident, R&D
|
SaleCommon Stock | 10,000 | $30.00 | $300,000.00 |
DisclosureSEC source: 0001209191-22-021388 · doc4.xml · nonDerivative · entry 2 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,926 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:11 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionCommon Stock | 10,000 | $4.12 | $41,200.00 |
DisclosureSEC source: 0001209191-22-021388 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| March 10, 2022 Filed Mar 12, 2022 00:02 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-22-018291 · doc4.xml · derivative · entry 3 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,456 Underlying: Common Stock · 10,000 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 10, 2022 Filed Mar 12, 2022 00:02 UTC |
Bergstrom Donald APresident, R&D
|
SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001209191-22-018291 · doc4.xml · nonDerivative · entry 2 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,926 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| March 10, 2022 Filed Mar 12, 2022 00:02 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionCommon Stock | 10,000 | $4.12 | $41,200.00 |
DisclosureSEC source: 0001209191-22-018291 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:31 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-22-015724 · doc4.xml · derivative · entry 3 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,456 Underlying: Common Stock · 8,000 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:31 UTC |
Bergstrom Donald APresident, R&D
|
SaleCommon Stock | 8,000 | $23.88 | $191,040.00 |
DisclosureSEC source: 0001209191-22-015724 · doc4.xml · nonDerivative · entry 2 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,926 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.23 to $24.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:31 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionCommon Stock | 8,000 | $4.12 | $32,960.00 |
DisclosureSEC source: 0001209191-22-015724 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 02:01 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-22-011991 · doc4.xml · derivative · entry 5 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,456 Underlying: Common Stock · 8,000 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 02:01 UTC |
Bergstrom Donald APresident, R&D
|
SaleCommon Stock | 2,752 | $20.97 | $57,709.44 |
DisclosureSEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 4 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,926 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F5 · price: This transaction was executed in multiple trades at prices ranging from $20.76 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 02:01 UTC |
Bergstrom Donald APresident, R&D
|
SaleCommon Stock | 12,242 | $20.94 | $256,347.48 |
DisclosureSEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 3 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,678 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F4 · price: This transaction was executed in multiple trades at prices ranging from $20.26 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 02:01 UTC |
Bergstrom Donald APresident, R&D
|
SaleCommon Stock | 8,000 | $20.94 | $167,520.00 |
DisclosureSEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 2 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,920 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F3 · price: This transaction was executed in multiple trades at prices ranging from $20.27 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 02:01 UTC |
Bergstrom Donald APresident, R&D
|
Exercise / conversionCommon Stock | 8,000 | $4.12 | $32,960.00 |
DisclosureSEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022. F2 · balance_after: Includes 93,387 shares underlying restricted stock units. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:25 UTC |
Patel SanjivDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 527,140 | $0.00 Strike: $20.38 | $0.00 |
DisclosureSEC source: 0001209191-22-005675 · doc4.xml · derivative · entry 1 Patel Sanjiv · CIK 0001816210 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,140 Underlying: Common Stock · 527,140 shares Expires 2032-01-26 F1 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:21 UTC |
Catinazzo ThomasChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 78,540 | $0.00 Strike: $20.38 | $0.00 |
DisclosureSEC source: 0001209191-22-005669 · doc4.xml · derivative · entry 2 Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,540 Underlying: Common Stock · 78,540 shares Expires 2032-01-26 F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:21 UTC |
Catinazzo ThomasChief Financial Officer
|
GrantCommon Stock | 39,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005669 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,259 F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. F2 · balance_after: Includes 52,165 shares underlying RSUs. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:28 UTC |
Porter AndyChief Administrative Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,340 | $0.00 Strike: $20.38 | $0.00 |
DisclosureSEC source: 0001209191-22-005682 · doc4.xml · derivative · entry 2 Porter Andy · CIK 0001899340 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,340 Underlying: Common Stock · 48,340 shares Expires 2032-01-26 F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:28 UTC |
Porter AndyChief Administrative Officer
|
GrantCommon Stock | 24,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005682 · doc4.xml · nonDerivative · entry 1 Porter Andy · CIK 0001899340 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,317 F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. F2 · balance_after: Includes 35,545 shares underlying RSUs. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:17 UTC |
Bergstrom Donald APresident, R&D
|
GrantStock Option (Right to Buy) · Derivative | 129,900 | $0.00 Strike: $20.38 | $0.00 |
DisclosureSEC source: 0001209191-22-005662 · doc4.xml · derivative · entry 2 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,900 Underlying: Common Stock · 129,900 shares Expires 2032-01-26 F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:17 UTC |
Bergstrom Donald APresident, R&D
|
GrantCommon Stock | 64,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005662 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,920 F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. F2 · balance_after: Includes 93,387 shares underlying RSUs. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:13 UTC |
Adams BrianChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 78,540 | $0.00 Strike: $20.38 | $0.00 |
DisclosureSEC source: 0001209191-22-005645 · doc4.xml · derivative · entry 2 Adams Brian · CIK 0001636994 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,540 Underlying: Common Stock · 78,540 shares Expires 2032-01-26 F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:13 UTC |
Adams BrianChief Legal Officer
|
GrantCommon Stock | 39,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005645 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,917 F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. F2 · balance_after: Includes 52,165 shares underlying RSUs. Read SEC document |
| December 31, 2021 Filed Jan 7, 2022 22:13 UTC |
Patel SanjivDirector · President and CEO
|
GrantCommon Stock | 658 | $26.10 | $17,173.80 |
DisclosureSEC source: 0001209191-22-002465 · doc4.xml · nonDerivative · entry 1 Patel Sanjiv · CIK 0001816210 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,740 F1 · kind: The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction. F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| December 31, 2021 Filed Jan 7, 2022 22:15 UTC |
Adams BrianGeneral Counsel
|
GrantCommon Stock | 658 | $26.10 | $17,173.80 |
DisclosureSEC source: 0001209191-22-002471 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,647 F1 · kind: The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction. F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021. F3 · balance_after: Includes 12,895 shares underlying RSUs. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 00:43 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
SaleCommon Stock | 295 | $33.10 | $9,764.50 |
DisclosureSEC source: 0001209191-21-071314 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,989 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 12,895 shares underlying RSUs. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 00:39 UTC |
Bergstrom Donald ASee Remarks
|
SaleCommon Stock | 649 | $33.10 | $21,481.90 |
DisclosureSEC source: 0001209191-21-071312 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,970 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 28,437 shares underlying RSUs. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 00:50 UTC |
Porter AndySee Remarks
|
SaleCommon Stock | 260 | $33.10 | $8,606.00 |
DisclosureSEC source: 0001209191-21-071318 · doc4.xml · nonDerivative · entry 1 Porter Andy · CIK 0001899340 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,147 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 875 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 11,375 shares underlying RSUs. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 00:31 UTC |
Adams BrianGeneral Counsel
|
SaleCommon Stock | 295 | $33.10 | $9,764.50 |
DisclosureSEC source: 0001209191-21-071308 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,989 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 12,895 shares underlying RSUs. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:14 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-21-064892 · doc4.xml · derivative · entry 3 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,543 Underlying: Common Stock · 22,500 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:14 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
SaleCommon Stock | 22,500 | $35.40 | $796,500.00 |
DisclosureSEC source: 0001209191-21-064892 · doc4.xml · nonDerivative · entry 2 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,284 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 13,887 shares underlying RSUs. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:14 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
Exercise / conversionCommon Stock | 22,500 | $4.12 | $92,700.00 |
DisclosureSEC source: 0001209191-21-064892 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020. F2 · balance_after: Includes 13,887 shares underlying RSUs. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:07 UTC |
Adams BrianGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-21-064872 · doc4.xml · derivative · entry 3 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,786 Underlying: Common Stock · 6,500 shares Expires 2028-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:07 UTC |
Adams BrianGeneral Counsel
|
SaleCommon Stock | 6,500 | $35.42 | $230,230.00 |
DisclosureSEC source: 0001209191-21-064872 · doc4.xml · nonDerivative · entry 2 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,284 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $35.03 to $35.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 13,887 shares underlying RSUs. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:07 UTC |
Adams BrianGeneral Counsel
|
Exercise / conversionCommon Stock | 6,500 | $4.12 | $26,780.00 |
DisclosureSEC source: 0001209191-21-064872 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020. F2 · balance_after: Includes 13,887 shares underlying RSUs. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 00:56 UTC |
Bergstrom Donald ASee Remarks
|
SaleCommon Stock | 30,000 | $34.15 | $1,024,500.00 |
DisclosureSEC source: 0001209191-21-061088 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,619 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.309 to $36.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 01:33 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
SaleCommon Stock | 293 | $36.87 | $10,802.91 |
DisclosureSEC source: 0001209191-21-057862 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,284 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 13,887 shares underlying RSUs. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 01:27 UTC |
Bergstrom Donald ASee Remarks
|
SaleCommon Stock | 646 | $36.87 | $23,818.02 |
DisclosureSEC source: 0001209191-21-057860 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,619 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 30,625 shares underlying RSUs. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 01:21 UTC |
Adams BrianGeneral Counsel
|
SaleCommon Stock | 293 | $36.87 | $10,802.91 |
DisclosureSEC source: 0001209191-21-057858 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,284 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 13,887 shares underlying RSUs. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 00:24 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-21-055783 · doc4.xml · derivative · entry 3 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,043 Underlying: Common Stock · 22,500 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020. F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 00:24 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
SaleCommon Stock | 22,500 | $35.00 | $787,500.00 |
DisclosureSEC source: 0001209191-21-055783 · doc4.xml · nonDerivative · entry 2 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,577 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 00:24 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
Exercise / conversionCommon Stock | 22,500 | $4.12 | $92,700.00 |
DisclosureSEC source: 0001209191-21-055783 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 00:27 UTC |
Adams BrianGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-21-055784 · doc4.xml · derivative · entry 3 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,286 Underlying: Common Stock · 6,500 shares Expires 2028-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 00:27 UTC |
Adams BrianGeneral Counsel
|
SaleCommon Stock | 6,500 | $35.02 | $227,630.00 |
DisclosureSEC source: 0001209191-21-055784 · doc4.xml · nonDerivative · entry 2 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,577 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 00:27 UTC |
Adams BrianGeneral Counsel
|
Exercise / conversionCommon Stock | 6,500 | $4.12 | $26,780.00 |
DisclosureSEC source: 0001209191-21-055784 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:26 UTC |
Catinazzo ThomasSenior Vice President, Finance
|
SaleCommon Stock | 293 | $35.81 | $10,492.33 |
DisclosureSEC source: 0001209191-21-044063 · doc4.xml · nonDerivative · entry 1 Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,577 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 991 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 14,879 shares underlying RSUs. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:28 UTC |
Adams BrianGeneral Counsel
|
SaleCommon Stock | 293 | $35.81 | $10,492.33 |
DisclosureSEC source: 0001209191-21-044065 · doc4.xml · nonDerivative · entry 1 Adams Brian · CIK 0001636994 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,577 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 991 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 14,879 shares underlying RSUs. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:25 UTC |
Bergstrom Donald ASee Remarks
|
SaleCommon Stock | 976 | $35.81 | $34,950.56 |
DisclosureSEC source: 0001209191-21-044062 · doc4.xml · nonDerivative · entry 1 Bergstrom Donald A · CIK 0001709772 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,265 F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. F2 · balance_after: Includes 32,812 shares underlying RSUs. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 23:38 UTC |
Bergstrom Donald ASee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 42,242 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001209191-21-041732 · doc4.xml · derivative · entry 3 Bergstrom Donald A · CIK 0001709772 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,456 Underlying: Common Stock · 42,242 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.